By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Rules-Based Medicine today said that it has acquired intellectual property assets covering biomarker technology from Satoris.

The deal includes biomarkers and biomarker panels for clinical research use for Alzheimer's disease, frontal temporal dementia, Parkinson's disease, and other central nervous system conditions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: researchers classify pancreatic cancer into four subtypes using sequencing, and more.

Genotyping analysis of measles in Ontario indicates the strain there didn't originate from Disneyland or Europe.

The UK Medical Research Council says the proposed path of a new train line could affect research at the Francis Crick Institute.

The House of Lords in the UK approves a bill to allow mitochondrial donation.